Target intelligence / Profile preview

Porcine circovirus type 2 (PCV2)

Target
PCV2
Molecular classification
Other (virus), its components include viral proteins such as Capsid protein (Cap), Replication protein (Rep)
01

Overview

Porcine circovirus type 2 is a small, non-enveloped icosahedral virus (17–21 nm diameter) with a circular single-stranded DNA genome of 1766–1768 nucleotides encoding several proteins, notably the capsid protein (Cap) and replication-associated proteins (Rep, Rep′). It is responsible for a wide spectrum of syndromes collectively termed porcine circovirus-associated diseases (PCVAD), causing significant economic loss in swine production globally. Infection leads to immunosuppression, lymphoid depletion, granulomatous inflammation, and can predispose pigs to secondary infections. The Cap protein is highly immunogenic and is used as the antigen in PCV2 vaccines to prevent disease. PCV2 evolves rapidly, leading to multiple genotypes (PCV2a–PCV2e), and remains a persistent challenge for swine health due to its ability to cause chronic, multi-organ disease and adapt to control measures

Other names
PCV2Porcine circovirus 2Porcine circovirus type IICircovirus type 2
02

Mechanism of action

Induction of protective immunity (antibody and cellular responses) via presentation of viral capsid antigen (Cap) to the swine immune system; Cap-based VLP vaccines trigger neutralizing antibody and cell-mediated immunity that block infection and limit disease

03

Biological functions

Infectionimmune evasionviral replicationinduction of apoptosis (through certain viral proteins such as ORF3)immunomodulation
04

Disease associations

Infectionprimary causative agent of: Post-weaning multi-systemic wasting syndrome (PMWS)Porcine circovirus-associated diseases (PCVAD), including PCV2 systemic disease (PCV2-SD)porcine dermatitis and nephropathy syndrome (PDNS)reproductive disordersrespiratory disease complex (PRDC)enteric disease
05

Safety considerations

Challenges include vaccine failure due to genetic diversity (genotype variability, antigenic drift)coinfections (PRRSV, parvovirus, etc.)and incomplete understanding of PCV2-associated disease mechanisms. PCV2 infection can be exacerbated by poor management, stress, or concurrent infections
06

Interacting drugs

Licensed vaccines containing virus-like particles (VLPs) of the Cap protein (e.g., Ingelvac CircoFLEX, Porcilis PCV, and others)
07

Biomarkers

PCV2 DNA (PCR detection)anti-PCV2 antibodies (serological detection)clinical signs such as lymphoid depletion, granulomatous inflammation, and characteristic histopathological lesions in lymph nodes, lung, and other tissues

Beyond the preview

Go deeper on Porcine circovirus type 2 (PCV2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Porcine circovirus type 2 (PCV2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call